Otitis: Clinical Trials

4 trials for Otitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 11Terminated 1

Follow Otitis: new trials by email Literature Review of Otitis trials Research Report on Otitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea
piperacillin 4% + tazobactam 0.5% + dexamethasone 0.1%, piperacillin 8% + tazobactam 1.0% + dexamethasone 0.1%, piperacillin 2% + tazobactam 0.25% - Otitis Media, Otorrhea
Phase 1 / Phase 2TerminatedYuhan Corporation1352016-06-012022-01-13
Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes
AL-60371/AL-817 otic suspension, Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension - Acute Otitis Media
Phase 2TerminatedAlcon Research842013-12-012017-12-06
Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance
Amoxicillin-Clavulanate, 10 days, Amoxicillin-Clavulanate, 5 days - Acute Otitis Media
Phase 2TerminatedAlejandro Hoberman5202012-01-012017-10-06
Topical Voltaren in Otitis Externa
diclofenac sodium, dexotc - Otitis Externa
Phase 2TerminatedSieff Medical Center202008-09-012016-04-20

Narrower conditions

Otitis Media (3)  ·  Otitis Externa (1)

Broader conditions

Ear Diseases (4)  ·  Otorhinolaryngologic Diseases (4)

Interventions

Amoxicillin-Potassium Clavulanate Combination (1)  ·  Ciprofloxacin (1)  ·  Dexamethasone (1)  ·  Diclofenac (1)  ·  Piperacillin (1)  ·  Tazobactam (1)

Sponsors

Alcon Research (1)  ·  Alejandro Hoberman (1)  ·  Sieff Medical Center (1)  ·  Yuhan Corporation (1)

Countries

Israel (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Alejandro Hoberman, MD (1)

Results publications

PMID 24911895, PMID 28002709, PMID 37171965, PMID 42572144